{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:54:06Z","timestamp":1774436046880,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Poultry Science"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.psj.2022.102225","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T21:26:54Z","timestamp":1664832414000},"page":"102225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of cyclosporine A or activated charcoal co-administration on the pharmacokinetics of enrofloxacin in chickens"],"prefix":"10.1016","volume":"102","author":[{"given":"Tsvetelina","family":"Petkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-9436","authenticated-orcid":false,"given":"Aneliya","family":"Milanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-1404","authenticated-orcid":false,"given":"B\u0142a\u017cej","family":"Po\u017aniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psj.2022.102225_bib0001","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1002\/jps.21233","article-title":"Fluoroquinolone efflux mediated by ABC transporters","volume":"97","author":"Alvarez","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0002","unstructured":"Anonymous. 2022. U.S. Food & Drug. Accessed Sept. 2022. https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers."},{"key":"10.1016\/j.psj.2022.102225_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/bdd.1809","article-title":"Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5","volume":"33","author":"Arakawa","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.psj.2022.102225_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/23144599.2020.1765720","article-title":"Pharmacokinetics and tissue residue of enrofloxacin in healthy, Eimeria-infected broiler chickens and those pre-treated with amprolium and toltrazuril","volume":"8","author":"Atef","year":"2020","journal-title":"Int. J. Vet. Sci. Med."},{"key":"10.1016\/j.psj.2022.102225_bib0005","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1124\/dmd.113.053140","article-title":"Overlapping substrate and inhibitor specificity of human and murine ABCG2","volume":"41","author":"Bakhsheshian","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.psj.2022.102225_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00257300","article-title":"Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients","volume":"15","author":"Bertault-P\u00e9r\u00e8s","year":"1985","journal-title":"Cancer Chemother. Pharmacol"},{"key":"10.1016\/j.psj.2022.102225_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3259073","article-title":"Validation of an UHPLC-MS\/MS method for screening of antimicrobial residues in eggs and their application to analyses of eggs from laying hens subjected to pharmacological treatment","volume":"2017","author":"Caldeira","year":"2017","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.psj.2022.102225_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics10030127","article-title":"The effects of synthetically modified natural compounds on ABC transporters","volume":"10","author":"Dantzic","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.psj.2022.102225_bib0009","first-page":"710","article-title":"Recent advances in the search of BCRP- and dual P-gp\/BCRP-based multidrug resistance modulators","volume":"2","author":"Dei","year":"2019","journal-title":"Cancer Drug. Resist"},{"key":"10.1016\/j.psj.2022.102225_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12917-020-02608-9","article-title":"The impact of therapeutic-dose induced intestinal enrofloxacin concentrations in healthy pigs on fecal Escherichia coli populations","volume":"16","author":"De Smet","year":"2020","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.psj.2022.102225_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228138","article-title":"The effect of enrofloxacin on enteric Escherichia coli: fitting a mathematical model to in vivo data","volume":"15","author":"Erwin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.psj.2022.102225_bib0012","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3389\/fmicb.2018.02190","article-title":"Dosing regimen of enrofloxacin impacts intestinal pharmacokinetics and the fecal microbiota in steers","volume":"9","author":"Ferguson","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.psj.2022.102225_bib0013","doi-asserted-by":"crossref","first-page":"e74150","DOI":"10.1371\/journal.pone.0074150","article-title":"Age related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psj.2022.102225_bib0014","doi-asserted-by":"crossref","first-page":"e87781","DOI":"10.1371\/journal.pone.0087781","article-title":"E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psj.2022.102225_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11259-006-3400-7","article-title":"Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys","volume":"30","author":"Haritova","year":"2006","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.psj.2022.102225_bib0016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2885.2008.00968.x","article-title":"Expression of MDR1, MRP2 and BCRP mRNA in tissues of turkeys","volume":"31","author":"Haritova","year":"2008","journal-title":"J. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0017","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2006.11.015","article-title":"Functional studies on the activity of efflux transporters in an ex vivo model with chicken splenocytes and evaluation of selected fluoroquinolones in this model","volume":"73","author":"Haritova","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0018","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/pharmaceutics13081286","article-title":"Assessing the functional redundancy between P-gp and BCRP in controlling the brain distribution and biliary excretion of dual substrates with PET imaging in mice","volume":"13","author":"Hern\u00e1ndez-Lozano","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.psj.2022.102225_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105854","article-title":"Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice","volume":"163","author":"Hern\u00e1ndez-Lozano","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2885.1999.00217.x","article-title":"Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens","volume":"22","author":"Knoll","year":"1999","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0021","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(90)90429-H","article-title":"Cyclosporine-induced changes in glomerular filtration rate and urea excretion","volume":"88","author":"Laskow","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.psj.2022.102225_bib0022","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s11095-016-2020-3","article-title":"Enhanced method for diagnosing pharmacometric models: random sampling from conditional distributions","volume":"33","author":"Lavielle","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.psj.2022.102225_bib0023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2885.2011.01313.x","article-title":"ABCG2 transporter: therapeutic and physiologic implications in veterinary species","volume":"35","author":"Mealey","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1211\/0022357011775820","article-title":"Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein","volume":"53","author":"Naruhashi","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0026","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/psp4.12161","article-title":"Model evaluation of continuous data pharmacometric models: metrics and graphics","volume":"6","author":"Nguyen","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.15547\/bjvm.1082","article-title":"Effect of treatment with enrofloxacin and Lactobacillus probiotics on ABCB1, ABCC2 and ABCG2 mRNA expression in poultry","volume":"21","author":"Pavlova","year":"2018","journal-title":"Bulg. J. Vet. Med."},{"key":"10.1016\/j.psj.2022.102225_bib0028","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/psp4.12141","article-title":"Modeling of large pharmacokinetic data using nonlinear mixed-effects: a paradigm shift in veterinary pharmacology. A case study with robenacoxib in cats","volume":"5","author":"Pelligand","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0029","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00071668.2017.1304531","article-title":"The influence of growth and E. coli endotoxaemia on amoxicillin pharmacokinetics in turkeys","volume":"58","author":"Po\u017aniak","year":"2017","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jvp.12833","article-title":"The influence of age and body weight gain on enrofloxacin pharmacokinetics in turkeys\u2014Allometric approach to dose optimization","volume":"43","author":"Po\u017aniak","year":"2020","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0031","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/antibiotics9120925","article-title":"Allometric optimization of enrofloxacin dosage in growing male turkeys: empirical evidence for improved internal exposure","volume":"9","author":"Po\u017aniak","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.psj.2022.102225_bib0032","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.2006.00744.x","article-title":"Interaction of enrofloxacin with breast cancer resistance protein (BCRP\/ABCG2): influence of flavonoids and role in milk secretion in sheep","volume":"29","author":"Pulido","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0033","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.psj.2022.102225_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fvets.2015.00080","article-title":"Pharmacokinetic-Pharmacodynamic modeling of enrofloxacin against Escherichia coli in broilers","volume":"2","author":"Sang","year":"2016","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.17221\/7883-VETMED","article-title":"Quinolones: a class of antimicrobial agents","volume":"46","author":"S\u00e1rk\u00f6zy","year":"2001","journal-title":"Vet. Med."},{"key":"10.1016\/j.psj.2022.102225_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rvsc.2021.01.017","article-title":"Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese","volume":"136","author":"Sartini","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0037","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejphar.2008.03.014","article-title":"Implications of ABC transporters on the disposition of typical veterinary medicinal products","volume":"585","author":"Schrickx","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0038","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pa.32.040192.001153","article-title":"Population pharmacokinetics\/dynamics","volume":"32","author":"Sheiner","year":"1992","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.psj.2022.102225_bib0039","doi-asserted-by":"crossref","first-page":"e13510","DOI":"10.1111\/ctr.13510","article-title":"Interactions between anti-infective agents and immunosuppressants-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Sparkes","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.psj.2022.102225_bib0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2005.02357.x","article-title":"Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males","volume":"59","author":"Stass","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psj.2022.102225_bib0041","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1090-0233(02)00165-X","article-title":"Strategic administration of enrofloxacin in poultry to achieve higher maximal serum concentrations","volume":"165","author":"Sumano","year":"2003","journal-title":"Vet J"},{"key":"10.1016\/j.psj.2022.102225_bib0048","author":"Sun"},{"key":"10.1016\/j.psj.2022.102225_bib0042","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/antibiotics10050604","article-title":"Enrofloxacin dose optimization for the treatment of colibacillosis in broiler chickens using a drinking behaviour pharmacokinetic model","volume":"10","author":"Temmerman","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.psj.2022.102225_bib0043","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2885.2001.00311.x","article-title":"The oral bioavailability of ibuprofen enantiomers in broiler chickens","volume":"24","author":"Vermeulen","year":"2001","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.psj.2022.102225_bib0044","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fvets.2019.00363","article-title":"Pharmacokinetic modeling of ceftiofur sodium using non-linear mixed-effects in healthy beagle dogs","volume":"6","author":"Wang","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12917-018-1698-3","article-title":"In vivo pharmacokinetic\/pharmacodynamic modeling of enrofloxacin against Escherichia coli in broiler chickens","volume":"14","author":"Xiao","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.psj.2022.102225_bib0046","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.3390\/ijms21197023","article-title":"Prediction of cyclosporin-mediated drug interaction using physiologically based pharmacokinetic model characterizing interplay of drug transporters and enzymes","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psj.2022.102225_bib0047","series-title":"Proc. EuroResidue VIII, Conference on Residues of Veterinary Drugs in Food.","article-title":"Veterinary drug analysis in animal origin food and feed and their relevant products: a modern multi-class, multi-residue method using UHPLC-MS\/MS","author":"Zhao","year":"2016"}],"container-title":["Poultry Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0032579122005211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0032579122005211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T22:46:09Z","timestamp":1758494769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0032579122005211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0032579122005211"],"URL":"https:\/\/doi.org\/10.1016\/j.psj.2022.102225","relation":{},"ISSN":["0032-5791"],"issn-type":[{"value":"0032-5791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of cyclosporine A or activated charcoal co-administration on the pharmacokinetics of enrofloxacin in chickens","name":"articletitle","label":"Article Title"},{"value":"Poultry Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psj.2022.102225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of Poultry Science Association Inc.","name":"copyright","label":"Copyright"}],"article-number":"102225"}}